These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 34856444)

  • 1. Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway.
    Chen L; Wang J; Cai X; Chen S; Zhang J; Li B; Chen W; Guo X; Luo H; Chen J
    Bioorg Chem; 2022 Feb; 119():105516. PubMed ID: 34856444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three Ru(II) complexes modulate the antioxidant transcription factor Nrf2 to overcome cisplatin resistance.
    Chen L; Tang H; Hu T; Wang J; Ouyang Q; Zhu X; Wang R; Huang W; Huang Z; Chen J
    J Inorg Biochem; 2024 Oct; 259():112666. PubMed ID: 39029397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity.
    Chen J; Wang J; Deng Y; Li B; Li C; Lin Y; Yang D; Zhang H; Chen L; Wang T
    Eur J Med Chem; 2020 Oct; 203():112562. PubMed ID: 32698112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclometalated ruthenium complexes overcome cisplatin resistance through PI3K/mTOR/Nrf2 signaling pathway.
    Chen L; Yu W; Tang H; Zhang S; Wang J; Ouyang Q; Guo M; Zhu X; Huang Z; Chen J
    Metallomics; 2024 Jan; 16(1):. PubMed ID: 38183290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction.
    Wang H; Wei J; Jiang H; Zhang Y; Jiang C; Ma X
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
    Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
    Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes.
    Chen J; Peng F; Zhang Y; Li B; She J; Jie X; Zou Z; Chen M; Chen L
    Eur J Med Chem; 2017 Nov; 140():104-117. PubMed ID: 28923379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action.
    Pavlović M; Nikolić S; Gligorijević N; Dojčinović B; Aranđelović S; Grgurić-Šipka S; Radulović S
    J Biol Inorg Chem; 2019 Mar; 24(2):297-310. PubMed ID: 30762123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
    Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
    Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization and anticancer mechanism studies of fluorinated cyclometalated ruthenium(ii) complexes.
    Wen Y; Ouyang C; Li Q; Rees TW; Qiu K; Ji L; Chao H
    Dalton Trans; 2020 Jun; 49(21):7044-7052. PubMed ID: 32406463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
    Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
    Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.
    Golbaghi G; Pitard I; Lucas M; Haghdoost MM; de Los Santos YL; Doucet N; Patten SA; Sanderson JT; Castonguay A
    Eur J Med Chem; 2020 Feb; 188():112030. PubMed ID: 31945643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclometalated Ru(II) β-carboline complexes induce cell cycle arrest and apoptosis in human HeLa cervical cancer cells via suppressing ERK and Akt signaling.
    Chen J; Deng Y; Wang J; Chen S; Peng F; He X; Liu M; Luo H; Zhang J; Chen L
    J Biol Inorg Chem; 2021 Oct; 26(7):793-808. PubMed ID: 34459988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of
    Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
    Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.
    Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A
    Eur J Med Chem; 2024 Oct; 276():116618. PubMed ID: 38972079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.